United Therapeutics Corp (UTHR)
363.13
-23.14
(-5.99%)
USD |
NASDAQ |
Nov 15, 16:00
363.13
0.00 (0.00%)
After-Hours: 16:55
United Therapeutics Gross Profit (Annual): 2.07B for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 2.07B |
December 31, 2022 | 1.785B |
December 31, 2021 | 1.563B |
December 31, 2020 | 1.375B |
December 31, 2019 | 1.331B |
December 31, 2018 | 1.429B |
December 31, 2017 | 1.620B |
December 31, 2016 | 1.526B |
December 31, 2015 | 1.397B |
December 31, 2014 | 1.163B |
December 31, 2013 | 985.86M |
December 31, 2012 | 796.78M |
December 31, 2011 | 654.28M |
Date | Value |
---|---|
December 31, 2010 | 525.22M |
December 31, 2009 | 324.53M |
December 31, 2008 | 251.43M |
December 31, 2007 | 188.68M |
December 31, 2006 | 142.60M |
December 31, 2005 | 103.60M |
December 31, 2004 | 65.34M |
December 31, 2003 | 46.56M |
December 31, 2002 | 24.66M |
December 31, 2001 | 2.595M |
December 31, 2000 | 0.3435M |
December 31, 1999 | -0.9635M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
1.331B
Minimum
2019
2.07B
Maximum
2023
1.625B
Average
1.563B
Median
2021
Gross Profit (Annual) Benchmarks
Liquidia Corp | 14.60M |
Pfizer Inc | 33.54B |
Tonix Pharmaceuticals Holding Corp | 3.027M |
Ardelyx Inc | 106.66M |
Cingulate Inc | -- |